pre-operative evaluations assessment in common · pdf file•medium risk –moderate to...
TRANSCRIPT
10/1/2017
1
Optimizing Outcomes with Preoperative Assessment
Monica Tombasco
MS, MSNA, FNP-BC, CRNASenior Lecturer
Fitzgerald Health Education Associates, North Andover, MA
Emergency Medicine Nurse Practitioner Huggins Hospital, Wolfeboro, NH
Certified Registered Nurse Anesthetist
Catholic Medical Center, Manchester, NH
Disclosure
• No real or potential conflict of interest to disclose.
• No off-label, experimental or investigational use of drugs or devices will be presented.
Fitzgerald Health Education Associates 2
Objectives
• Upon completion of this program
the participant will:
– Demonstrate knowledge of the
myths and facts related to
preoperative clearance.
– Apply to practice knowledge of
current and future trends for surgical
procedures done in the United States.
Fitzgerald Health Education Associates 3
10/1/2017
2
Fitzgerald Health Education Associates 4
• Upon completion of this program
the participant will: (cont.)
– Demonstrate knowledge of the
American Society of Anesthesiologists
risk stratification of patients
undergoing surgery.
Objectives (continued)
Fitzgerald Health Education Associates 5
• Upon completion of this program the participant will: (cont.)
– Improve practice based on the knowledge learned from evidence-based recommendations for preoperative patient preparation, including: Diagnostic and ancillary testing needed according to patient comorbidities, age, and types of surgery proposed.
Objectives (continued)
References
• Listed at the end of the program
Fitzgerald Health Education Associates 6
10/1/2017
3
True or False
• “Medical clearance” for surgery can imply that the surgery will go well.
Fitzgerald Health Education Associates 7
False
• Even with proper evaluation, any surgical procedure can lead to complications.
• The purpose of the preoperative evaluation is to identify and treat the patient’s medical risks. It cannot predict surgical outcomes.
Fitzgerald Health Education Associates 8
Fact (continued)
• Types of surgery most commonly performed in older patients include– TURP
– Cataract repair
– Orthopedic procedures
– Abdominal aortic aneurysm repair
Fitzgerald Health Education Associates 9
10/1/2017
4
Fact (continued)
• The risk of death during surgery is 5–10% in those aged 65 years and above, compared to 0.9% up to age 65.
Fitzgerald Health Education Associates 10
Fact (continued)
• People over age 65 years comprise 11% of the population.
• Persons older than age 65 years will increase 25–35% over the next 30 years and undergo 20–40% of surgical procedures and account for 50% of surgical emergencies.
Fitzgerald Health Education Associates 11
Goals of Preoperative Assessment
• Optimize patient care and comfort.• Minimize perioperative morbidity
and mortality.• Evaluate the patient’s health status,
determining if any preoperative investigations and specialty consultations are required.
• Provide time-efficient and cost-effective patient evaluation.
Fitzgerald Health Education Associates 12
10/1/2017
5
Surgical Risk Classification
• High risk – High physiologic impact
– EBL>500 mL
– Could place the patient in a critical care state
• Examples: AAA surgery, surgery with large fluid shifts, multiple orthopedic procedures
Fitzgerald Health Education Associates 13
Surgical Risk Classification (continued)
• Medium risk
– Moderate to significantly invasive procedure
– EBL<500 mL
• Examples: CEA, most orthopedic surgeries, open prostate surgery, intra-abdominal, endovascular, and intrathoracic procedures
Fitzgerald Health Education Associates 14
Surgical Risk Classification (continued)
• Low risk
– Minimal impact to patient
– Minimally invasive procedure
– Little or no blood loss
• Examples: Endoscopic procedures, cataracts, breast biopsy
Fitzgerald Health Education Associates 15
10/1/2017
6
Functional Class
• 1=Normal healthy patient
• 2=Patient with mild systemic disease
• 3=Patient with severe systemic disease
• 4=Patient with incapacitating disease that is a constant threat to life
Fitzgerald Health Education Associates 16
ASA Assignment of Physical Classification
• Class 1– Normal healthy patient
• Class 2– Systemic disease that results in no
functional limitations (well-controlled)• HTN• DM• Chronic bronchitis• Morbid obesity• Extremes of age (<1 yr and >70 yr)
Fitzgerald Health Education Associates 17
ASA Assignment of Physical Classification
(continued)
• Class 3
– A patient with severe systemic disease that results in functional limitations
• Poorly controlled HTN
• DM with vascular complications
• Angina pectoris
• Prior MI
• Pulmonary disease that limits activity
Fitzgerald Health Education Associates 18
10/1/2017
7
• Class 4
– A patient with severe systemic disease that is a constant threat of life
• Unstable angina
• Advanced pulmonary, renal or hepatic dysfunction
Fitzgerald Health Education Associates 19
ASA Assignment of Physical Classification
(continued)
• Class 5
– A moribund patient who is not expected to survive without the operation
• Ruptured AAA
• PE
• Head injury with increased ICP
Fitzgerald Health Education Associates 20
ASA Assignment of Physical Classification
(continued)
ASA Assignment of Physical Classification
(continued)• Class E Emergency
– Any patient in whom an emergency operation is required
• Class 6
– A declared brain dead patient whose organs are being removed for donor purposes
Fitzgerald Health Education Associates 21
10/1/2017
8
General Information
• Do the preoperative workup close enough to the date of surgery so that the test results are current for the anesthesia provider and surgeon.
• 10 days before surgery is a good time to start the workup.
Fitzgerald Health Education Associates 22
General History
Fitzgerald Health Education Associates 23
Nutritional Status
• Suboptimal nutrition is a main contributor to postoperative complications.
• Gradual weight loss may be experienced with aging.
• A rapid weight loss can indicate an underlying disease.
Fitzgerald Health Education Associates 24
10/1/2017
9
Nutritional Status (continued)
• Malnourishment is defined as a greater
than 5% weight loss in 1 month or
greater than 10% over 6 months.
• Serum albumin less than 3.2 g/dL (32
g/L) or lymphocyte count <3,000 can
indicate malnourishment.
Fitzgerald Health Education Associates 25
Nutritional Status(continued)
• Normals– WBC: 6,000–10,000 × 103/microliter
– Lymphs: 20–40% WBC
– Absolute lymphs: 1,000–3,500 cells/microliter
• Example– Total WBC: 2,800 × 103/microliter
– % lymphocytes: 15%
– Absolute lymphocytes: 420 cells/microliter
Fitzgerald Health Education Associates 26
Nutrition
• Causes of malnutrition can range from the surgical condition of the patient to social isolation, financial constraints, poor dentition, depression, occult malignancy, or severe infection.
Fitzgerald Health Education Associates 27
10/1/2017
10
Nutrition (continued)
• Obesity
– A higher incidence of undiagnosed CV disease and diabetes in the obese population with a BMI of greater than 27 kg/m2
– Increase wound dehiscence and infection as sub-Q fat layer enlarges
Fitzgerald Health Education Associates 28
Nutrition (continued)
• Obesity (cont.)
– Increased risk of pulmonary complications from abdominal content pressure on the diaphragm
– Anesthesia difficulties
Fitzgerald Health Education Associates 29
Emotional State Legal State
• Depression, fear, and anxiety should be considered.
• Competency issues must be addressed prior to the patient signing an informed consent.
• Guardianship and power of attorney should be identified if necessary.
Fitzgerald Health Education Associates 30
10/1/2017
11
Allergies
• Latex
• Iodine, contrast dye, shellfish
• Antibiotics
• Adhesives
• Local anesthetics
• “Delineate true allergy from a known adverse effect”
Fitzgerald Health Education Associates 31
Past Medical History
• CV/pulmonary/diabetes
• All past medical issues including a personal history of bleeding disorders/bleeding diathesis
• HIV/hepatitis
• Organ transplant/artificial joints
• Pregnancy
Fitzgerald Health Education Associates 32
Surgical History
Fitzgerald Health Education Associates 33
10/1/2017
12
Immunizations
• Update immunizations at time of preoperative physical evaluation.
Fitzgerald Health Education Associates 34
Social History
• Smoking history
• ETOH
• Recreational drugs
• Caffeine intake
Fitzgerald Health Education Associates 35
Social History (continued)
• Smoking: Increased secretions, increased risk of pulmonary complications
– Stop smoking 8 weeks prior to surgery.
Fitzgerald Health Education Associates 36
10/1/2017
13
Social History (continued)
• ETOH: Patients can develop postoperative withdrawal (delirium tremens).
Fitzgerald Health Education Associates 37
Medications
•Medications patient is taking
•Opioids: Chronic use can build tolerance.
•Vasoactive drugs: In combination with MAOIs or TCAs can lead to HTN/ hypotension crisis and lethal hyperthermia
Fitzgerald Health Education Associates 38
Family History
10/1/2017
14
Anesthetic Implications
• Patient and blood relative anesthetic history
– Malignant hyperthermia
– G6PD deficiency
– Neurological disorders
– PONV
– Sickle cell disease
– Difficult intubation in past
– Dentition
– Neck or jaw immobility
– Hoarseness
Fitzgerald Health Education Associates 40
Medical Evaluation
Fitzgerald Health Education Associates 41
Cardiac Evaluation
• The most common adverse events following surgery are cardio-pulmonary.
– Accounting for 40% of deaths
Fitzgerald Health Education Associates 42
10/1/2017
15
Cardiac Evaluation(continued)
• Patient’s capacity to increase cardiac output in response to intra-operative and postoperative stress is one of the most fundamental aspects of outcome after surgery.
Fitzgerald Health Education Associates 43
Cardiac Evaluation(continued)
• 50,000 patients experience perioperative MI/year.
• 1 million patients experience perioperative cardiac complications/year.
• Major postoperative complications include cardiac arrhythmias, CHF, acute MI, and cardiac death.
Fitzgerald Health Education Associates 44
Cardiac Evaluation (continued)
• Is the surgery needed? Is it emergent or elective?
• Has the patient undergone revascularization in the last 5 years?
• Has the patient received a recent coronary evaluation?
Fitzgerald Health Education Associates 45
10/1/2017
16
Cardiac Evaluation (continued)
• If procedure is emergent and the patient’s life depends on it, the patient must proceed for surgery.
• If elective, further workup may be necessary to determine the presence of underlying cardiac disease (CAD, CHF, valvular disease, arrhythmias).
Fitzgerald Health Education Associates 46
Cardiac Evaluation (continued)
• Depending on the results of the workup, the patient may be cleared for surgery, treated medically, or referred for invasive testing.
• This may lead to coronary revascularization prior to an elective procedure.
Fitzgerald Health Education Associates 47
Cardiac Evaluation
• Note: (*) on slides denotes updated information from recently revised 2014 ACC/AHA guidelines on Perioperative Evaluation and Management of Patients undergoing Noncardiac Surgery (Executive: a report on the ACC/AHA Task Force on Practice Guidelines (published online ahead of print August 1, 2014), Circulation 2014.
Fitzgerald Health Education Associates 48
10/1/2017
17
Cardiac Evaluation (continued)
• (*) Initial evaluation for elective surgery involves review of the patient’s medical history, physical examination, functional status evaluation
Fitzgerald Health Education Associates 49
Cardiac Evaluation (continued)
• History
– Preexisting cardiac disease
– Disease severity, stability and prior treatment
– Comorbidity: DM, CKD, CHF, AS, unstable angina, cerebrovascular disease, recent MI, *PAD
– Type of surgery to be performed
Fitzgerald Health Education Associates 50
Cardiac Evaluation (continued)
• Risk stratification: High risk or unstable: Need cardiac issues resolved before undergoing a surgical procedure
– Revascularization within the past 6 weeks
– CHF worsening or new onset
– *EF of <35% at rest increases perioperative risk
Fitzgerald Health Education Associates 51
10/1/2017
18
Cardiac Evaluation(continued)
• MI in last 3 months
– Risk of reinfarction after an elective procedure performed within 3 months of the MI exceeds 30% and decreases to 4.6% after 6 months.
• CABG<6 weeks prior to elective procedure
• Malignant or symptomatic arrhythmias/high grade AV blocks
• Age>70 years
Fitzgerald Health Education Associates 52
Cardiac Evaluation (continued)
• Severe valvular disease aortic stenosis with valve area of <1 cm square or symptomatic mitral disease
Fitzgerald Health Education Associates 53
Cardiac Evaluation (continued)
• Intermediate risk patients:
– Generally can proceed to surgery if their functional status is adequate
• Functional capacity ≥ to 4 METS
• Hx of ischemic heart disease
• Controlled CAD
Fitzgerald Health Education Associates 54
10/1/2017
19
Cardiac Evaluation (continued)
• Hx of compensated CHF or prior heart failure
• Cerebral vascular disease (hx of stroke or TIA)
• DM
• Renal insufficiency
• *Low ejection fraction at rest<35%
Fitzgerald Health Education Associates 55
Cardiac Evaluation (continued)
• Low risk:
– Patients can proceed to surgery without additional cardiac workup, unless scheduled for high-risk procedures or have poor functional capacity.
– Prior CABS/PCI>6 yrs without ischemic symptoms
Fitzgerald Health Education Associates 56
Cardiac Evaluation(continued)
• Low risk (cont.):
– Recent revascularization>3 months, negative stress test in past 2 years
– HTN– Controlled
– LVH– Stable
Fitzgerald Health Education Associates 57
10/1/2017
20
Cardiac Evaluation (continued)
• Functional status
– Can you take care of yourself?
– Walk indoors around the house?
– Walk a block or 2 on level ground at 2–3 mph?
• Equivalent 1–4 METs
Fitzgerald Health Education Associates 58
Cardiac Evaluation (continued)
• Functional status (cont.)
– Can you climb up a flight of stairs or walk up a hill?
– Run a short distance?
– Do heavy work around the house?
– Golfing, bowling, dancing?
• Equivalent of 4–10 METS
Fitzgerald Health Education Associates 59
Cardiac Evaluation (continued)
• Functional status (cont.)
– Can you participate in strenuous sports like swimming, football, basketball or skiing?
• Equivalent of greater than 10 METs
Fitzgerald Health Education Associates 60
10/1/2017
21
Cardiac Evaluation (continued)
• Physical examination– Overall appearance
– Funduscopic examination
– Neck– JVD, bruits
– Heart– Heart sounds, murmurs, LVH, BP
– Lungs
– Abdomen
– Extremities– Edema
– Neurologic
Fitzgerald Health Education Associates 61
Cardiac Evaluation(continued)
Cardiac Testing
Fitzgerald Health Education Associates 62
Cardiac Evaluation (continued)
• *Preoperative resting 12-lead ECG is reasonable in persons with known CAD, significant arrhythmia, PAD, CVD or significant structural heart disease, except if undergoing low-risk procedures.
Fitzgerald Health Education Associates 63
10/1/2017
22
• *Preoperative resting 12-lead ECG may be reasonable in asymptomatic patients without known CAD, except for those undergoing low-risk procedures.
Fitzgerald Health Education Associates 64
Cardiac Evaluation (continued)
Cardiac Evaluation (continued)
• Preoperative resting 12-lead ECGs are not indicated in asymptomatic persons undergoing low-risk surgical procedures.
Fitzgerald Health Education Associates 65
Cardiac Evaluation (continued)
• *ECG findings of significance include:– High-degree AVB
– Arrhythmias
– Bradycardia
– BBB
– Prolonged QT
– LVH
– ST depressions
Fitzgerald Health Education Associates 66
10/1/2017
23
Cardiac Evaluation(continued)
• Optimal interval between obtaining a 12-lead ECG and elective surgery is ?.
• In general 1 to 3 months interval is adequate for stable patients.
Fitzgerald Health Education Associates 67
Cardiac Evaluation (continued)
• Holter monitoring
– Holter monitoring is useful in documenting arrhythmias.
Fitzgerald Health Education Associates 68
Cardiac Evaluation (continued)
• *Exercise stress testing
– If elevated risk and excellent functional capacity (>10 METs), it is reasonable to forgo further exercise testing and cardiac imaging and proceed to surgery.
– If elevated risk and unknown functional capacity, it may be reasonable to perform exercise stress test to assess functional capacity if it will change management.
Fitzgerald Health Education Associates 69
10/1/2017
24
Cardiac Evaluation (continued)
• *Exercise stress testing (cont.)
– If elevated risk and moderate functional capacity (4 to 10 METs), it is reasonable to forgo exercise testing with cardiac imaging and proceed to surgery.
Fitzgerald Health Education Associates 70
Cardiac Evaluation(continued)
• *Exercise stress testing (cont.)
– If elevated risk and poor (<4 METs) or unknown functional capacity, it is reasonable to perform exercise testing with cardiac imaging to assess for ischemia if it will change management.
– Routine screening is not useful for patients at low risk for noncardiac surgery.
Fitzgerald Health Education Associates 71
Cardiac Evaluation (continued)
Pharmacological stress testing
• *Reasonable if elevated risk and poor functional capacity (METs <4), dobutamine stress echocardiogram or pharmacological stress test (adenosine or dipyridamole) with thallium and/or technetium-99 and rubidium-82
Fitzgerald Health Education Associates 72
10/1/2017
25
Cardiac Evaluation (continued)
LV function
• *It is reasonable for patients with dyspnea of unknown origin to undergo preoperative LV function testing.
Echocardiogram
Fitzgerald Health Education Associates 73
Cardiac Evaluation(continued)
• *LV function (cont.)
– It is reasonable in patients with heart failure with worsening dyspnea or other change in clinical status to undergo preoperative evaluation of LV function
Fitzgerald Health Education Associates 74
Fitzgerald Health Education Associates 75
• *LV function (cont.)
– Reassessment of LV function in clinically stable patients with previously documented LV dysfunction may be considered if there has been no assessment within a year.
– Routine preoperative evaluation of LV function is not recommended.
Cardiac Evaluation(continued)
10/1/2017
26
Cardiac Evaluation
Cardiac Evaluation(continued)
• *Timing of elective noncardiac surgery in patients with previous PCI
– Elective noncardiac surgery should be delayed within 14 days after balloon angioplasty, 30 days of bare-metal stent implantation or within 12 months of drug-eluting coronary stent implantation.
Fitzgerald Health Education Associates 77
Fitzgerald Health Education Associates 78
• *Timing of elective noncardiac surgery in patients with previous PCI (cont.)
– Elective noncardiac surgery after DES may be considered after 180 days if risk of further delay is greater than the expected risks of ischemia or stent thrombosis.
Cardiac Evaluation(continued)
10/1/2017
27
Cardiac Evaluation(continued)
• *Timing of elective noncardiac surgery in patients with previous PCI (cont.)
– Elective noncardiac surgery should not be performed within 30 days after BMS or within 12 months after DES when dual antiplatelet therapy will need to be discontinued postoperatively.
Fitzgerald Health Education Associates 79
Cardiac Evaluation(continued)
Cardiac Evaluation(continued)
• *Timing of elective noncardiac surgery…(cont.)– Elective noncardiac
surgery should not be performed within 14 days of balloon angioplasty in patients in whom ASA will need to be discontinued postoperatively.
Fitzgerald Health Education Associates 81
10/1/2017
28
Cardiac Evaluation(continued)
• *PCI before noncardiac surgery should be limited to patients with left main disease whose comorbidities preclude CABG and those with unstable CAD who would be appropriate candidates for emergency or urgent revascularization.
Fitzgerald Health Education Associates 82
Cardiac Evaluation(continued)
• *Patients whose evaluation recommends CABG surgery should undergo coronary revascularization before an elevated-risk surgical procedure.
Fitzgerald Health Education Associates 83
Cardiac Evaluation (continued)
• Antibiotics
– Antibiotic prophylaxis for bacterial endocarditis is utilized for
• Prosthetic cardiac valve or prosthetic material used for cardiac valve repair
• Previous infective endocarditis
• Congenital heart disease
• Cardiac transplantation recipients
Fitzgerald Health Education Associates 84
10/1/2017
29
Cardiac Evaluation (continued)
• Hypertension
– Controlled HTN does not appear to increase perioperative risk, uncontrolled HTN does.
– Uncontrolled HTN increases risk of bleeding during surgery and hematoma formation.
Fitzgerald Health Education Associates 85
Cardiac Evaluation (continued)
• Patients with pacemakers or defibrillators should be identified.
Fitzgerald Health Education Associates 86
Pulmonary Evaluation
• Postoperative pulmonary complications occur more often in patients– Age 60 years
and older
– Respiratory symptoms (URI, asthma COPD)
Fitzgerald Health Education Associates 87
10/1/2017
30
Pulmonary Evaluation (continued)
• Postoperative pulmonary complications occur…(cont.)– Abnormal findings on PE– Abnormal chest x-ray– Current smoking history– Longer than 3 hours
anesthetic time– Surgery at upper abdomen
or thoracic site
Fitzgerald Health Education Associates 88
Pulmonary Evaluation (continued)
• Patients with COPD or asthma must have those conditions stabilized before undergoing surgery.
• Pulmonary consult may be necessary.
Fitzgerald Health Education Associates 89
Pulmonary Evaluation (continued)
• An ABG analysis, chest x-ray, and PFTs should be ordered for all patients with pulmonary disease.
• Explain to the patient with severe pulmonary disease that a respirator could be necessary after surgery.
• Patients with URI may need to have surgery cancelled until infection has cleared due to increased respiratory complications.
Fitzgerald Health Education Associates 90
10/1/2017
31
Pulmonary Evaluation (continued)
• Predicting airway difficulty by history– Surgery in and
around the airway
– Recent trauma face, neck, chest
– Tumor/irradiation
– Nasal fracture
– Goiter
– Obesity
Fitzgerald Health Education Associates 91
Pulmonary Evaluation (continued)
• Mallampati airway assessment: Evaluation of airway difficulty
– Patient sitting erect, have them open mouth and look in posterior pharynx
– Mallampati
• Class 1
– Soft palate, uvula, pillars present
Fitzgerald Health Education Associates 92
Pulmonary Evaluation (continued)
• Mallampati airway assessment: (cont.)
– Mallampati (cont.)
• Class 2
– Soft palate, uvula
• Class 3– Soft palate, base of uvula present
• Class 4– Hard palate visible only
Fitzgerald Health Education Associates 93
10/1/2017
32
Mallampati Airway Assessment
Fitzgerald Health Education Associates 94
Pulmonary Evaluation (continued)
• The patient who smokes should stop smoking at least 8 weeks before surgery.
Fitzgerald Health Education Associates 95
Endocrine Evaluation
• The objectives of the endocrine evaluation
– To rule out the existence of DM, thyroid disease, or other endocrine issues
Fitzgerald Health Education Associates 96
10/1/2017
33
Endocrine Evaluation(continued)
• Diabetes mellitus
– How well is the disease controlled?
– Consequences of poorly controlled disease
Fitzgerald Health Education Associates 97
True or False
• You would advise your patient to take his/her normal oral diabetic medications the day of a planned surgery.
False!
Fitzgerald Health Education Associates 98
Endocrine Evaluation (continued)
• Oral diabetic medications should not be administered the day of a planned surgery in type 2 DM.
• Elevated BS will be covered by short-acting regular insulin.
Fitzgerald Health Education Associates 99
10/1/2017
34
Endocrine Evaluation (continued)
• Type 1 diabetics will have their BS managed by boluses of regular insulin; their AM regular insulin dose will be held and in most; 1/3 dose of their AM long-acting will be given DOS.
Fitzgerald Health Education Associates 100
Endocrine Evaluation (continued)
• Patients on insulin pumps should be managed with endocrine and anesthesia consult.
– Basal rate should be continued.
Fitzgerald Health Education Associates 101
Endocrine Evaluation (continued)
• A general target for intraoperative maintenance of blood glucose is 140–180 mg/dL (7.77–9.99 mmol/L).
• Complications of poorly controlled DM include DKA and HHNK/HHS and higher risk of postoperative infection.
Fitzgerald Health Education Associates 102
10/1/2017
35
Endocrine Evaluation (continued)
• Chronic hyperglycemia can lead to glycosylation of tissue proteins and a limited-mobility joint syndrome.
Fitzgerald Health Education Associates 103
Endocrine Evaluation (continued)
• Thyroid
– Patients should be euthyroid before surgery.
– Patients who are mildly hypothyroid can proceed to surgery.
– Patients with hyperthyroidism should be made euthyroid unless surgical emergency.
Fitzgerald Health Education Associates 104
Endocrine Evaluation (continued)
• Thyroid and anti-thyroid medications should be taken through the morning of surgery.
Fitzgerald Health Education Associates 105
10/1/2017
36
Endocrine Evaluation (continued)
• Adrenal cortical disorders
– Adrenal insufficiency (deficiency of adrenal cortical function) can be triggered in corticosteroid-dependent patients who do not receive increased doses of corticosteroid during periods of stress (surgery).
Fitzgerald Health Education Associates 106
Endocrine Evaluation (continued)
• Symptoms of adrenal suppression include:
– Cardiovascular collapse
– Hyponatremia
– Hyperkalemia
– Severe volume depletion
– Mental status changes
Fitzgerald Health Education Associates 107
Endocrine Evaluation (continued)
• All patients who have received the equivalent of 5 mg of prednisone by any route (topical, inhalation, or oral) for more than 2 weeks any time in the past 12 months should be considered unable to respond to surgical stress.
Fitzgerald Health Education Associates 108
10/1/2017
37
Renal Evaluation
• Acute renal failure is the cause of death in 20% of elderly patients post-operatively.
Fitzgerald Health Education Associates 109
Renal Evaluation (continued)
• Renal disease can contribute to bleeding because of a functional platelet deficit associated with renal impairment.
• Renal dysfunction leads to– Anemia
– Electrolyte disturbances
– Peripheral neuropathy
Fitzgerald Health Education Associates 110
Renal Evaluation (continued)
• When vasodilatation and hypotension occurs during surgery, these patients can experience cardiac arrest and renal failure.
Fitzgerald Health Education Associates 111
10/1/2017
38
Renal Evaluation (continued)
• Most accurate reflection of renal reserve (GFR) is creatinine clearance. It reflects the ability of glomeruli to excrete creatinine into the urine at a given blood concentration.
Fitzgerald Health Education Associates 112
GI Evaluation
• GI diseases increase the risk for– Aspiration of
gastric content
– Dehydration
– Electrolyte disturbance
– Anemia
Fitzgerald Health Education Associates 113
GI Evaluation (continued)
• In a patient with a history of liver disease, PT and INR testing are warranted to rule out coagulopathy.
Fitzgerald Health Education Associates 114
10/1/2017
39
Hematology Evaluation
• A CBC is probably indicated in most surgical patients, although it is not always ordered.
Fitzgerald Health Education Associates 115
Hematology Evaluation (continued)
• PT, INR, PTT, ACT, and platelets are indicated if there is evidence of
– A bleeding disorder in the H&P
– A family history of coagulopathy
– If the patient is on antithrombolytic therapy
– If high risk surgical procedures are entertained
Fitzgerald Health Education Associates 116
WBC Differential
• Infection
• Disease of WBCs
• Undergoing radiation or chemotherapy
• Hypersplenism
• Aplastic anemia
Fitzgerald Health Education Associates 117
10/1/2017
40
Neurologic Evaluation
• Patients with neurologic diseases can undergo surgery, but the specific condition and medical management must be carefully noted.
Fitzgerald Health Education Associates 118
Neurologic Evaluation (continued)
• High risk patient’s include those with bruits or cardiovascular disease.
– Can require duplex ultrasound of the carotids to evaluate for significant stenosis>70%
Fitzgerald Health Education Associates 119
Neurologic Evaluation (continued)
• Therapeutic medical management preoperatively may or may not prevent a seizure during surgery.
• Continue patients on their anti-seizure medications up until the day of surgery.
Fitzgerald Health Education Associates 120
10/1/2017
41
Neurologic Evaluation (continued)
• Patients with dementia or preoperative delirium are at greater risk for developing postoperative delirium.
Fitzgerald Health Education Associates 121
Neurologic Evaluation (continued)
• Independent risk factors for delirium include– Advanced age– MI– Hypoxia– Hypotension– Dementia– Stroke
Fitzgerald Health Education Associates 122
– Constipation– Ulcer– Bleeding– Trauma– Pain– Infection
Neurologic Evaluation (continued)
• Independent risk factors for delirium include (cont.)– Hypoalbuminemia – Medications– Sensory deprivation– Urinary retention– Electrolyte abnormalities
Fitzgerald Health Education Associates 123
10/1/2017
42
Ancillary Testing
Fitzgerald Health Education Associates 124
ECG
• Rheumatic fever/heart murmurs
• Heart disease
• Known or suspected cardiac abnormalities
• SOB with climbing 1 flight of stairs or running a short distance
• HTN
Fitzgerald Health Education Associates 125
CBC
• Potentially bloody operation
• Known anemia
• Bleeding disorder
• Hematologic malignancy
• CRF
• Undergoing radiation and chemotherapy
Fitzgerald Health Education Associates 126
10/1/2017
43
Electrolytes
• Age over 60 years
• Use of diuretics
• Renal disease
• HTN/cardiac disease, DM
• Fluid or electrolyte abnormality (SIADH, DI, liver disease, fever, diarrhea)
Fitzgerald Health Education Associates 127
Comprehensive Chemistry Profile
• Age>60 years
• DM
• Renal disease
• Cardiac disease
• Adrenal, pituitary, liver, GI, pancreatic, parathyroid disease, radiation or chemotherapy
Fitzgerald Health Education Associates 128
Coagulation Testing
• Known or suspected coagulation disorder
• Anticoagulant therapy
• Hemorrhage or anemia
• Thrombosis
• Liver disease, renal disease
• Malabsorption or poor nutrition
Fitzgerald Health Education Associates 129
10/1/2017
44
Urinalysis
•DM
•UTI
•Renal disease
•Electrolyte and some endocrine disorders
Fitzgerald Health Education Associates 130
Thyroid
• Routine thyroid studies– TSH
Fitzgerald Health Education Associates 131
Pregnancy Test
• Urine or serum pregnancy test in all women of childbearing age with intact ovaries and uterus
Fitzgerald Health Education Associates 132
10/1/2017
45
Chest X-ray
• All patients with pulmonary/ cardiac disease
• Surgery near or at the level of thorax and diaphragm
• Age>50 years (questionable)
• Smokers with no other risk factors age 50 years and beyond
Fitzgerald Health Education Associates 133
Medications– General Guidelines
• *Give beta blockers the AM of surgery if previously on them.
• *ACEI and ARBS– Consider continuing or discontinuing
the AM of OR
• *Continue CA channel blockers
• Continue statins
Fitzgerald Health Education Associates 134
Medications– General Guidelines (continued)
• Clopidogrel (Plavix®) & other P2Y12 Inhibitors
– Consult surgeon/cardiology
– Discontinue 7 days before OR
– Do not discontinue clopidogrel (Plavix®) with drug-eluting stent (DES) until they have completed 12 months of anti-platelet therapy.
Fitzgerald Health Education Associates 135
10/1/2017
46
Fitzgerald Health Education Associates 136
• Clopidogrel (Plavix®) & other P2Y12 Inhibitors (cont.)– Do not discontinue clopidogrel
(Plavix®) with bare-metal stent (BMS) until they have completed 1 month of antiplatelet therapy.
Medications– General Guidelines (continued)
Medications– General Guidelines (continued)
• Warfarin should be discontinued 5 days prior to OR.
– Check INR– Must be 1.5 or below especially if undergoing surgery with high-risk bleeding risk
– Consult with surgeon
Fitzgerald Health Education Associates 137
Medications– General Guidelines (continued)
• ASA/ASA containing products
– Follow guidelines for management of antiplatelet therapy for discontinuation
– Continue if patient has a cardiac stent
Fitzgerald Health Education Associates 138
10/1/2017
47
Medications– General Guidelines (continued)
• Factor Xa Inhibitors (dabigatran [Pradaxa®]) should be discontinued 1–2 days before OR if GFR is normal or 3–5 days before OR if GFR is decreased.
– Consult with surgeon/cardiologist
Fitzgerald Health Education Associates 139
Medications– General Guidelines(continued)
• Atrial fibrillation
– Warfarin can be discontinued without interim use of heparin except in high-risk patients with A-Fib.
• Hx of previous embolization, known atrial thrombus
• Consult cardiology
Fitzgerald Health Education Associates 140
Medications– General Guidelines(continued)
• Patients with heart-valve prosthesis substitute unfractionated heparin or LMWH (bridging) for warfarin
– Discontinue heparin 6 hours before surgery
– Monitor PTT
– With LMWH– Discontinue 12–24 hours before surgery with general anesthesia
Fitzgerald Health Education Associates 141
10/1/2017
48
Medications– General Guidelines(continued)
• NSAIDs
– COX-1 inhibitors–Discontinue 7 days before OR
– COX-2 inhibitors have no effect on platelets.
Fitzgerald Health Education Associates 142
• Corticosteroids
– Chronic steroid use prior to surgery will require additional doses to prevent adrenal crisis.
– Chronic use of steroids can also delay wound healing and increase the risk for infection.
Fitzgerald Health Education Associates 143
Medications– General Guidelines(continued)
Medications– General Guidelines (continued)
• Contraceptives
– For major surgeries if on contraception (combined estrogen and progesterone)
• Switch to alternative contraception 4–6 wks before OR
Or
• Continue combined estrogen and progesterone and receive LMWH
Fitzgerald Health Education Associates 144
10/1/2017
49
Medications– General Guidelines (continued)
• Psychotropic agents
– Continue SSRIs, SNRIs, neuroleptics, and benzodiazepines before OR
Fitzgerald Health Education Associates 145
Medications– General Guidelines (continued)
• OTC products with antiplatelet/anticoagulation properties: 4Gs, 3Fs, L&C and others
• Discontinue 2 weeks before an elective surgical procedure
Fitzgerald Health Education Associates 146
Medications– General Guidelines (continued)
• 4Gs
– Garlic, ginger, ginseng, gingko
• 3Fs
– Feverfew, fish oil, fenugreek
• L&C
– Licorice, coenzyme Q10
Fitzgerald Health Education Associates 147
10/1/2017
50
Advanced Directives
• If patient is severely or terminally ill discuss with them a plan in case they can no longer make decisions!
Fitzgerald Health Education Associates 148
End of Presentation Thank you for your time and attention.
Monica Tombasco,
MS, MSNA, FNP-BC, CRNA
www.fhea.com [email protected]
Fitzgerald Health Education Associates 149
References
• *2014 ACC/AHA Guidelines on Perioperative Cardiovasclar Evaluation and Care for Noncardiac Surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
• Guillermo, U. Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline. January 2012.
Fitzgerald Health Education Associates 150
10/1/2017
51
References(continued)
• Jassal D., Neilan T., Sharma S. Perioperative cardiac management. Available at http://emedicine.medscape.com/article/285328-overview
• Nutritional Supplements and Perioperative Evaluation. Available online at http://www.uptodate.com/contents/overview-of-perioperative-nutritional-support
Fitzgerald Health Education Associates 151
References(continued)
• Riddell JW., Chiche L., Plaude B., Harmon M., Coronary stents and noncardiac surgery. Circulation. 2007;116:e378-e382.
• Schwartz, R., Preoperative Evaluation and Management. Available at http://emedicine.medscape.com/article/1127055-overview
Fitzgerald Health Education Associates 152
• Images/Illustrations: Unless otherwise noted, all images/illustrations are from open sources, such as the CDC or Wikipedia or property of FHEA or author.
• All websites listed active at the time of publication.
Fitzgerald Health Education Associates 153
10/1/2017
52
Copyright Notice
Copyright by Fitzgerald Health Education AssociatesAll rights reserved. No part of this publication may be reproduced or transmitted
in any form or by any means, electronic or mechanical, including photocopy, recording or any information storage and retrieval system, without permission
from Fitzgerald Health Education Associates
Requests for permission to make copies of any part of the work should be mailed to:
Fitzgerald Health Education Associates
85 Flagship Drive
North Andover, MA 01845-6184
Fitzgerald Health Education Associates 154
Statement of Liability
• The information in this program has been thoroughly researched and checked for accuracy. However, clinical practice and techniques are a dynamic process and new information becomes available daily. Prudent practice dictates that the clinician consult further sources prior to applying information obtained from this program, whether in printed, visual or verbal form.
• Fitzgerald Health Education Associates disclaims any liability, loss, injury or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents of this presentation.
Fitzgerald Health Education Associates 155
Fitzgerald Health Education Associates
85 Flagship Drive
North Andover, MA 01845-6154978.794.8366 Fax-978.794.2455
Website: fhea.com
Learning & Testing Center: fhea.com/npexpert
www.facebook.com/fitzgeraldhealth
@npcert
Fitzgerald Health Education Associates 156